BRD4 and neoplasm: NHWD-870, a novel BRD4 inhibitor that suppresses the secretion of macrophage colony-stimulating factor (CSF)-1 by tumor cells and disrupts the BRD4/HIF-1α axis, is currently under preclinical investigation for the treatment of CM [233].